Agios Pharmaceuticals, Inc. (AGIO) shares outstanding

Shares outstanding · fiscal 2025
57.97M

Agios Pharmaceuticals, Inc. (AGIO) had 57.97M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.1% higher than the 57.89M of fiscal 2024. Figures as of 18 Nov 2026, 12:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
57.97M
Change on fiscal 2024
+0.1%
Growth, 5 years
−3.4% a year
Highest on record
69.00Mfiscal 2020
Lowest on record
54.79Mfiscal 2022
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Agios Pharmaceuticals, Inc. shares outstanding, in more detail

The market data feed counts 59.81M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 3.4% a year. Across the 7 fiscal years on record (2019–2025), the highest was 69.00M in fiscal 2020 and the lowest 54.79M in fiscal 2022.

History · 7 fiscal years

Shares outstanding by fiscal year

Agios Pharmaceuticals, Inc. shares outstanding, year by year

Agios Pharmaceuticals, Inc. (AGIO) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202557.97M 0.1% up
202457.89M 4.0% up
202355.65M 1.6% up
202254.79M 9.4% down
202160.45M 12.4% down
202069.00M 15.0% up
201959.99M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on AGIO

Agios Pharmaceuticals, Inc., figure by figure

Agios Pharmaceuticals, Inc. (AGIO) overview: price, valuation and scorecard

Agios Pharmaceuticals, Inc. shares outstanding: questions and answers

How many shares does Agios Pharmaceuticals, Inc. have?

Agios Pharmaceuticals, Inc. (AGIO) had 57.97M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.1% higher than the 57.89M of fiscal 2024. The market data feed counts 59.81M shares outstanding today.

What is the growth rate of Agios Pharmaceuticals, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 3.4% a year.

What are the highest and lowest diluted share count figures on record for Agios Pharmaceuticals, Inc.?

Across the 7 fiscal years on record (2019–2025), the highest was 69.00M in fiscal 2020 and the lowest 54.79M in fiscal 2022.

How is Agios Pharmaceuticals, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Agios Pharmaceuticals, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Agios Pharmaceuticals, Inc. (AGIO) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/AGIO/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.